Prescription Drug Costs a Worry for Consumers
Drug Topics
SEPTEMBER 1, 2022
Survey participants said their drug costs have gone up and almost a third had trouble paying for food and housing because of high drug costs.
Thu.Sep 01, 2022
469 
CMS coverage policies restrict patient access to important treatment options for Alzheimer’s disease
PhRMA
SEPTEMBER 1, 2022
There’s been a lot of discussion this year about the Centers for Medicare & Medicaid Services (CMS) national coverage determination (NCD) for new Alzheimer’s treatments finalized earlier this year in April. Their policy, finalized this past April, puts in place barriers between Alzheimer’s patients in Medicare and potentially life-changing treatment.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Another Lot of Propofol Recalled
Drug Topics
SEPTEMBER 1, 2022
This recall of propofol because of particulates seen in vials follows a previous one in July 2022.
First 90 Days: Adaptive Biotech’s Tycho Peterson
PharmaVoice
SEPTEMBER 1, 2022
A long-time analyst, Tycho Peterson brings his business savvy to the C-suite at Adaptive, where he began as CFO in June with a knowledge of what works and what doesn't in the diagnostics space.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Preschoolers and Asymptomatic COVID-19 Cases: More Likely Than in Other Ages?
Drug Topics
SEPTEMBER 1, 2022
Findings show more than one-third of infected preschoolers are asymptomatic. The results call into question COVID-19 prevention strategies based on screening young children for symptoms.
Pharma’s renewed sickle cell investment lifts a once-shirked disease
PharmaVoice
SEPTEMBER 1, 2022
Pfizer's $5.4 billion deal to acquire Global Blood Therapeutics invigorated the fast-growing market, and patients are fit to be the benefactors.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Majority of retail pharmacists fear losing Medicare-eligible patients
Drug Store News
SEPTEMBER 1, 2022
Seventy percent of pharmacists who responded to EnlivenHealth's survey said that a third or more of their pharmacy's revenue comes from Medicare-eligible patients.
Expert Discusses Pharmacy Technician Training, Essential for Catching Burnout-Related Mistakes
Pharmacy Times
SEPTEMBER 1, 2022
Bill Schimmel, CEO and executive director of the Pharmacy Technician Certification Board (PTCB), discusses how pharmacy technicians can face burnout and advocate for themselves.
Walmart obtains minority stake in Sustainable Beef
Drug Store News
SEPTEMBER 1, 2022
Walmart and Sustainable Beef will work collaboratively to increase visibility in the beef supply chain and help ranchers grow their business.
A Large Proportion of Medical Students Experience Migraines, Choose to Self-Manage Symptoms
Pharmacy Times
SEPTEMBER 1, 2022
Though around 42% of medical students in study experience headaches, many of these causing significant functional disability, most choose to self-manage symptoms with sleep and medication.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Costco’s sales on the rise
Drug Store News
SEPTEMBER 1, 2022
The membership warehouse club has revealed that its net sales climbed 15.3% to top $70.8 billion and shoppers rang up $222.7 billion in net sales, a 15.9% increase from fiscal 2021.
Olanzapine, Samidorphan Prove Effective in Treating Bipolar 1 Disorder, Schizophrenia
Pharmacy Times
SEPTEMBER 1, 2022
Study results show that the risk of gaining 10% or more of body weight from the baseline fell 50% when patients were on the combination.
Lupin obtains tentative nod, approval for 2 generics
Drug Store News
SEPTEMBER 1, 2022
Generic Sprycel is indicated for adults with a certain type of chronic myeloid leukemia and generic Pristiq is used to treat depression.
Considerations for Maintaining Payer Network Access in the World of Vertical Integration – Part 2: Abusive PBM Practices and Tools for Providers to Combat Them
Pharmacy Times
SEPTEMBER 1, 2022
An overview of the legal and business tools available to community, specialty, hospital, and health-system pharmacies in seeking to maintain payer network access and combat abusive practices.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Hungary will deploy Brainomix AI stroke software nationwide
pharmaphorum
SEPTEMBER 1, 2022
UK medtech company Brainomix has claimed its first national contract – from Hungary – for its artificial intelligence-based platform used to improve diagnosis and treatment of people with suspected stroke from medical images. The platform – called e-Stroke – is already deployed in hundreds of hospitals across the UK, other countries in Europe and Asia as well as the US but this is the first time that it has been the subject of a nationwide tender, according to the Oxford-based company.
Amorepacific acquires Tata Harper
Drug Store News
SEPTEMBER 1, 2022
Amorepacific has entered into a definitive agreement to acquire Tata Harper.
AZ blocks former exec from taking up role at GSK – for now
pharmaphorum
SEPTEMBER 1, 2022
AstraZeneca has succeeded in a last-gasp effort to stop its former head of investor relations joining rival UK pharma group GSK, after winning an injunction in the High Court in London. Chris Sheldon ended an almost 19-year career at AZ in August, working his way up from a lab role and holding a series of senior positions at the company, most recently as head of investor relations.
Opinion: ‘Food is medicine’ interventions should be the main course at White House nutrition conference
STAT
SEPTEMBER 1, 2022
Much of the public’s perceptions around food as an intervention for health are dated. So are the U.S. government’s perceptions and its health care policies. Not by a matter of years, but by decades. The last time the nation focused on food — from the top — was the 1969 White House Conference on Food, Nutrition, and Health.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Dr. B: Expanding the business model from COVID vaccines to antiviral medications
pharmaphorum
SEPTEMBER 1, 2022
Cyrus Massoumi, founder of Dr. B, tells us about his online platform that makes physician assessment readily available to patients and provides access to COVID-19 therapeutics that may otherwise be difficult to obtain. COVID-19 antiviral medications Paxlovid (nirmatrelvir/ritonavir) and Lagevrio (molnupiravir) must be taken within five days of the onset of symptoms, but obtaining these medications within that window is difficult for some.
Opinion: Public health needs to be transformed. Health IT can help
STAT
SEPTEMBER 1, 2022
Covid-19 pummeled public health agencies and organizations. Future crises, whether from infectious disease, extreme weather, or other sources, are likely to do the same unless they change their approach to public health reporting, data management, and information exchange. Managing public health is not easy, especially in the United States. Not only is this country home to diverse populations that have varying genetic predispositions and cultural patterns of medical significance, it is also geog
Study: Children as Young as Age Four Can Self-Swab for COVID-19
Pharmacy Times
SEPTEMBER 1, 2022
School-aged children that self-swabbed for COVID-19 did so with almost as much accuracy as a health care provider, which could ease strain on school health care systems.
Listen: The anti-aging research boom, the Godfather of biotech, & the future of Biogen
STAT
SEPTEMBER 1, 2022
What can worms teach us about immortality? How does one become the Godfather? And where does Biogen go from here? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Megan Molteni joins us to explain the scientific discoveries, rampant hype, and Silicon Valley billions behind the burgeoning field of longevity research.
Pharmacists Can Prepare for Growing Role in Holistic Health and Wellness Efforts
Pharmacy Times
SEPTEMBER 1, 2022
Rina Shah, PharmD, discussed the growing role for pharmacists in encouraging holistic health and wellness for patients.
STAT+: Illumina wins case against FTC in bid to hold onto early cancer detection company Grail
STAT
SEPTEMBER 1, 2022
SAN DIEGO — Sequencing behemoth Illumina on Thursday won its case against the Federal Trade Commission in its bid to hold onto Grail, a Bay Area early cancer detection company that the genomics giant acquired for $8 billion last year. An administrative law judge rejected the FTC’s argument that the San Diego company’s acquisition of Grail would quash competition in the nascent market for multi-cancer early detection, a technology that picks up on a wide range of cancer types
Cold Sore-Causing Herpes Simplex 1 Traced Back to Prehistoric Roots
Pharmacy Times
SEPTEMBER 1, 2022
Viral DNA samples from 4 ancient cadavers suggest that HSV-1 transmission boomed with Bronze Age migrations and the introduction of kissing as a romantic and sexual cultural practice.
STAT+: Calm’s head of science departs amid a shakeup at meditation app maker
STAT
SEPTEMBER 1, 2022
In 2021, Jennifer Huberty left her post in academia to become the first full-time head of science at Calm. She set about building a team to beef up the multibillion dollar meditation app’s bonafides, hiring researchers from Harvard, Brown, and other prestigious institutions. A year later, Huberty has departed the company to strike out on her own as a scientific consultant for digital health companies, and the future of her science team and the company’s broader research efforts is
Effective Treatment for Some Patients with Arndt-Gottron Syndrome Can Be Achieved With IVIG
Pharmacy Times
SEPTEMBER 1, 2022
Though there is no well-defined therapeutic approach to the treatment of Arndt-Gottron syndrome, intravenous immunoglobulins have been documented as a well-tolerated treatment in some cases.
Merck and Guardant expand partnership to develop cancer therapies
Pharmaceutical Technology
SEPTEMBER 1, 2022
Guardant Health has extended a partnership with Merck KGaA, Darmstadt, Germany, to aid in expediting precision oncology therapeutics development. Under the collaboration, the companies will use the GuardantINFORM real-world evidence (RWE) platform to boost works for developing Merck’s precision cancer pipeline. The development of therapies for key oncology indications with substantial unmet needs will be the expanded partnership’s focus.
Pharmacy Focus: Public Health Matters- Using VaxiTaxi to Promote Better Public Health
Pharmacy Times
SEPTEMBER 1, 2022
VaxiTaxi is aimed to deliver immunity to the community, whether it is a high risk patient, busy family, or a needle shy/needlephobic.
Novartis lines up Merck exec to replace R&D leader Jay Bradner
pharmaphorum
SEPTEMBER 1, 2022
Jay Bradner, president of the Novartis Institutes for Biomedical Research (NIBR), is retiring from the position after seven years in the role, and will be replaced by Merck & Co R&D executive Fiona Marshall. Novartis said this morning that Bradner (pictured above left) – who is also stepping down from the executive committee – is leaving to “pursue a next chapter of scientific contribution and leadership” outside the company.
Inflation Reduction Act Takes Multiple Approaches to Improve Drug Access, Affordability
Pharmacy Times
SEPTEMBER 1, 2022
Although it may not have immediate significant impacts for many patients, the Inflation Reduction Act could open the door for future changes.
What Do You Need to Know About the New ANCC FNP Exam Blueprint?
Board Vitals - Pharmacist
SEPTEMBER 1, 2022
The American Nurses Credentialing Center (ANCC) has announced several changes to its Family Nurse Practitioner (FNP) certification exam. What do these changes mean for you, and how can you prepare for the new test? When does the new ANCC content outline take effect? The new test content outline will take effect with ANCC FNP exams administered on Sept. 28, 2022, and later.
Experts: The Pharmaceutical Industry Is Settling Into a “New Normal,” 2.5 Years Into the COVID-19 Pandemic
Pharmacy Times
SEPTEMBER 1, 2022
Scott Biggs and Doug Long of IQVIA discussed where the pharmacy industry stands now and what they predict for the future.
Let's personalize your content